4 March 2026 │ Presentations and Keynotes

Topas Therapeutics will present at the 9th Antigen-Specific Immune Tolerance Summit in Boston on 4 March 2026. The presentation will highlight Topas’ approach to assessing antigen-specific immune tolerance induction and advancing precision immunotherapies, including TPM502 for celiac disease.